menu search

Veterinary oncology market is projected to reach us$ 800 million by 2033 | fact.mr report

North America to Lead Global Veterinary oncology Market over the Decade Rockville, Oct. 06, 2023 (GLOBE...

October 6, 2023, 7:00 am

Umoja biopharma to present at the 2023 cell & gene meeting on the mesa

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) — Umoja Biopharma, Inc., a transformative immuno-oncology com...

October 5, 2023, 6:30 pm

Artios to present initial phase 1 clinical monotherapy data for atr inhibitor art0380 in advanced solid tumors at the european society of medical oncology congress 2023

ART0380 is a highly competitive, wholly owned ATR inhibitor with broad clinical application alone or in combination for DDR deficient and high replica...

October 5, 2023, 12:00 pm

Novartis to present new oncology data at esmo 2023 demonstrating practice-changing innovation in advanced prostate and early breast cancer

Basel, October 5, 2023 — Novartis will present new data from 29 Novartis and investigator-led abstracts at the European Society for Medical ...

October 5, 2023, 1:15 am

Verastem: signs of life for a beaten-down equity

Verastem is a biotechnology company focused on developing novel agents for solid tumors, with its main candidate being avutometinib. Avutometinib is b...

October 4, 2023, 9:00 pm

Alx oncology announces proposed public offering

SOUTH SAN FRANCISCO, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) — ALX oncology Holdings Inc., (“ALX ...

October 4, 2023, 8:10 pm

Revolution medicines to present new clinical data at major oncology conferences and host investor webcast

Interim Data to be Presented for RMC-6236 (RASMULTI(ON) Inhibitor) and RMC-6291 (RASG12C(ON) Inhibitor) Company to Host Investor Webcast Following ESM...

October 4, 2023, 8:05 pm

Immuneering to present preclinical data on imm-1-104 and imm-6-415 at aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage o...

October 4, 2023, 4:05 pm

What makes kura oncology (kura) a new buy stock

Kura oncology (KURA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the ...

October 4, 2023, 1:31 pm

Black diamond therapeutics to present preclinical and clinical data at the aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision ...

October 4, 2023, 12:14 pm

Kura oncology announces three presentations at aacr-nci-eortc international conference on molecular targets and cancer therapeutics

– Presentations to highlight preclinical data supporting combination of KO-2806 with targeted therapies, including TKIs, KRASG12C inhibitors and KRA...

October 4, 2023, 11:30 am

Tg therapeutics: racing against time while their differentiators are still relevant

TG Therapeutics has transitioned from a developer of oncology drugs to a commercial-stage neurology com...

October 3, 2023, 2:26 pm

Why shares of point biopharma global are soaring tuesday

Point Biopharma focuses on oncology therapies. The company's lead therapy is PNT2002 to treat prostate ...

October 3, 2023, 1:52 pm

Alx oncology stock doubles on early data from phase ii cancer trial

ALX oncology Holdings Inc saw its stock value double in pre-market trading on the heels of promising ...

October 3, 2023, 8:47 am

Wework shares dip as it skips interest payments, and other movers

Shares of ALX oncology Holdings Inc. ALXO, +0.21% surged 20% after the company said it would discuss in...

October 3, 2023, 5:17 am

Volitionrx to unveil new cancer detection method insights at upcoming webinar

VolitionRx (NYSE-A:VNRX) Limited has announced that it is participating in a webinar hosted by Edison Group, to expound new cancer data to be presente...

October 2, 2023, 9:22 am

Transcode therapeutics announces closing of $8.5 million public offering

BOSTON, Sept. 28, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA ...

September 28, 2023, 8:02 pm

Why guardant health stock jumped 15% this week

Analysts at both Bernstein and Piper Sandler had good things to say about Guardant Health this week. Shares of the precision ...

September 28, 2023, 4:22 pm

Kineta announces participation at october investor conferences

SEATTLE, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu...

September 28, 2023, 9:30 am

Aclaris therapeutics: the many lives of this biopharmaceutical developer

Aclaris Therapeutics is a developer of kinome-based medicines for immune-inflammatory and oncology indi...

September 28, 2023, 7:18 am


Search within

Pages Search Results: